Ali SM - Search Results

1

Serum HER-2/neu and response to the aromatase inhibitor letrozole versus tamoxifen.

Lipton A, Ali SM, Leitzel K, Demers L, Harvey HA, Chaudri-Ross HA, Brady C, Wyld P, Carney W. Lipton A, et al. Among authors: ali sm. J Clin Oncol. 2003 May 15;21(10):1967-72. doi: 10.1200/JCO.2003.09.098. J Clin Oncol. 2003. PMID: 12743150 Clinical Trial.

2

Safety and efficacy of bisphosphonates beyond 24 months in cancer patients.

Ali SM, Esteva FJ, Hortobagyi G, Harvey H, Seaman J, Knight R, Costa L, Lipton A. Ali SM, et al. J Clin Oncol. 2001 Jul 15;19(14):3434-7. doi: 10.1200/JCO.2001.19.14.3434. J Clin Oncol. 2001. PMID: 11454892 Clinical Trial.

3

Elevated serum Her-2/neu level predicts decreased response to hormone therapy in metastatic breast cancer.

Lipton A, Ali SM, Leitzel K, Demers L, Chinchilli V, Engle L, Harvey HA, Brady C, Nalin CM, Dugan M, Carney W, Allard J. Lipton A, et al. Among authors: ali sm. J Clin Oncol. 2002 Mar 15;20(6):1467-72. doi: 10.1200/JCO.2002.20.6.1467. J Clin Oncol. 2002. PMID: 11896093 Clinical Trial.

4

Baseline serum NTx levels are prognostic in metastatic breast cancer patients with bone-only metastasis.

Ali SM, Demers LM, Leitzel K, Harvey HA, Clemens D, Mallinak N, Engle L, Chinchilli V, Costa L, Brady C, Seaman J, Lipton A. Ali SM, et al. Ann Oncol. 2004 Mar;15(3):455-9. doi: 10.1093/annonc/mdh089. Ann Oncol. 2004. PMID: 14998848 Free article. Clinical Trial.

5

Metastatic breast cancer: overview of treatment.

Ali SM, Harvey HA, Lipton A. Ali SM, et al. Clin Orthop Relat Res. 2003 Oct;(415 Suppl):S132-7. doi: 10.1097/01.blo.0000092981.12414.7b. Clin Orthop Relat Res. 2003. PMID: 14600603 Review.

6

Elevated plasma endoglin (CD105) predicts decreased response and survival in a metastatic breast cancer trial of hormone therapy.

Vo MN, Evans M, Leitzel K, Ali SM, Wilson M, Demers L, Evans DB, Lipton A. Vo MN, et al. Among authors: ali sm. Breast Cancer Res Treat. 2010 Feb;119(3):767-71. doi: 10.1007/s10549-008-0261-5. Epub 2008 Dec 30. Breast Cancer Res Treat. 2010. PMID: 19115106 Clinical Trial.

7

Identification of a subpopulation of metastatic breast cancer patients with very high HER2 expression levels and possible resistance to trastuzumab.

Bates M, Sperinde J, Köstler WJ, Ali SM, Leitzel K, Fuchs EM, Paquet A, Lie Y, Sherwood T, Horvat R, Singer CF, Winslow J, Weidler JM, Huang W, Lipton A. Bates M, et al. Among authors: ali sm. Ann Oncol. 2011 Sep;22(9):2014-2020. doi: 10.1093/annonc/mdq706. Epub 2011 Feb 2. Ann Oncol. 2011. PMID: 21289364 Free article.

8

Elevation in multiple serum inflammatory biomarkers predicts survival of pancreatic cancer patients with inoperable disease.

Alkhateeb A, Zubritsky L, Kinsman B, Leitzel K, Campbell-Baird C, Ali SM, Connor J, Lipton A. Alkhateeb A, et al. Among authors: ali sm. J Gastrointest Cancer. 2014 Jun;45(2):161-7. doi: 10.1007/s12029-013-9564-9. J Gastrointest Cancer. 2014. PMID: 24446242 Clinical Trial.

9

Bone markers in the management of metastatic bone disease.

Lipton A, Costa L, Ali SM, Demers LM. Lipton A, et al. Among authors: ali sm. Cancer Treat Rev. 2001 Jun;27(3):181-5. doi: 10.1053/ctrv.2000.0212. Cancer Treat Rev. 2001. PMID: 11417969 Review.

10

Response of an ERBB2-mutated inflammatory breast carcinoma to human epidermal growth factor receptor 2-targeted therapy.

Ali SM, Alpaugh RK, Downing SR, Stephens PJ, Yu JQ, Wu H, Buell JK, Miller VA, Lipson D, Palmer GA, Ross JS, Cristofanilli M. Ali SM, et al. J Clin Oncol. 2014 Sep 1;32(25):e88-91. doi: 10.1200/JCO.2013.49.0599. Epub 2014 Feb 10. J Clin Oncol. 2014. PMID: 24516025 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,362 results

Search Page

Filters